Evidence map›Paper›PMID 22727867›Full record

ArticleThe Journal of pediatrics2012

A rating scale for the functional assessment of patients with familial dysautonomia (Riley Day syndrome).

Felicia B Axelrod, Linda Rolnitzky, Gabrielle Gold von Simson, Dena Berlin, Horacio Kaufmann

Abstract readEvaluation Study
In one paragraph

Article in The Journal of pediatrics, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Case Series: Management of Neurotrophic Keratitis from Familial Dysautonomia.Optometry and vision science : official publication of the American Academy of Optometry · 2018
    Article
  5. Ambulatory blood pressure profiles in familial dysautonomia.Clinical autonomic research : official journal of the Clinical Autonomic Research Society · 2018
    Article
  6. The familial dysautonomia disease geneDisease models & mechanisms · 2017
    Article
  7. The application of clinical genetics · 2017
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Felicia B AxelrodDepartment of Pediatrics, New York University School of Medicine, New York, NY, USA. Felicia.Axelrod@nyumc.org
Linda Rolnitzky
Gabrielle Gold von Simson
Dena Berlin
Horacio Kaufmann

Funding

INSTITUTIONAL CLINICAL AND TRANSLATIONAL SCIENCE AWARDUL1RR029893 · NCRR · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI CRONSTEIN, BRUCE NEIL · 2009 to 2011
$17.7M
Training CoreU54NS065736 · NINDS · VANDERBILT UNIVERSITY MEDICAL CENTER · PI BIAGGIONI, ITALO · 2009 to 2018
$11.6M
Carbidopa for the treatment of nausea and vomiting in familial dysautonomiaIND #R01FD003731 · FDA · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI KAUFMANN, HORACIO · 2009 to 2010
$366k
FDA HHS R01 FD003731FDA HHS R01-FD003731-01NCRR NIH HHS 1UL1RR029893NCRR NIH HHS UL1 RR029893NINDS NIH HHS U54 NS065736NINDS NIH HHS U54-NS065736-01
6 · The paper itself

Abstract

objectiveTo develop a reliable rating scale to assess functional capacity in children with familial dysautonomia, evaluate changes over time, and determine whether severity within a particular functional category at a young age affected survival. STUDY

designTen functional categories were retrospectively assessed in 123 patients with familial dysautonomia at age 7 years ± 6 months. Each of the 10 Functional Severity Scale categories (motor development, cognitive ability, psychological status, expressive speech, balance, oral coordination, frequency of dysautonomic crisis, respiratory, cardiovascular, and nutritional status) were scored from 1 (worst or severely affected) to 5 (best or no impairment). Changes over time were analyzed further in 22 of the 123 patients who were also available at ages 17 and 27 years.

resultsSeverely impaired cardiovascular function and high frequency of dysautonomic crisis negatively affected survival (P < .005 and P < .001, respectively). In the 22 individuals followed up to age 27 years, psychological status significantly worsened (P = .01), and expressive speech improved (P = .045). From age 17 to 27 years, balance worsened markedly (P = .048).

conclusionThe Functional Severity Scale is a reliable tool to measure functional capacity in patients with familial dysautonomia. The scale may prove useful in providing prognosis and as a complementary endpoint in clinical trials.

Indexed as

Disease ProgressionSeverity of Illness IndexAdolescentAdultAge FactorsChildDysautonomia, FamilialFemaleHumansKaplan-Meier EstimateMaleObserver VariationPrognosisRetrospective StudiesSurvival Rate

Identifiers

PMID22727867
PMCPMC3534733

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.